These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10951469)

  • 1. Screening for fragile X syndrome in women of reproductive age.
    Pesso R; Berkenstadt M; Cuckle H; Gak E; Peleg L; Frydman M; Barkai G
    Prenat Diagn; 2000 Aug; 20(8):611-4. PubMed ID: 10951469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
    Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
    Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
    Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
    Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics.
    Ryynänen M; Kirkinen P; Mannermaa A; Saarikoski S
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1236-9. PubMed ID: 7726262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.
    Obstet Gynecol; 2010 Oct; 116(4):1008-1010. PubMed ID: 20859177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of 30 fetuses at risk for fragile X syndrome.
    Grasso M; Perroni L; Colella S; Piombo G; Argusti A; Lituania M; Buscaglia M; Giussani U; Grimoldi MG; Bricarelli FD
    Am J Med Genet; 1996 Jul; 64(1):187-90. PubMed ID: 8826473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population screening for fragile-X syndrome.
    Bonthron D; Strain L
    Lancet; 1993 Mar; 341(8847):769-70. PubMed ID: 8095681
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fragile X syndrome: implications of molecular genetics for the clinical syndrome.
    Rousseau F
    Eur J Clin Invest; 1994 Jan; 24(1):1-10. PubMed ID: 8187801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of X-linked mental retardation with fragile (X) using fetoscopy and fetal blood sampling.
    Webb T; Gosden CM; Rodeck CH; Hamill MA; Eason PE
    Prenat Diagn; 1983; 3(2):131-7. PubMed ID: 6622392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for fragile X syndrome: a literature review and modelling study.
    Song FJ; Barton P; Sleightholme V; Yao GL; Fry-Smith A
    Health Technol Assess; 2003; 7(16):1-106. PubMed ID: 12969542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X syndrome carrier screening in pregnant women in Chinese Han population.
    Hung CC; Lee CN; Wang YC; Chen CL; Lin TK; Su YN; Lin MW; Kang J; Tai YY; Hsu WW; Lin SY
    Sci Rep; 2019 Oct; 9(1):15456. PubMed ID: 31664061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic DNA markers in prenatal diagnosis of fragile X syndrome.
    Oberlé I; Mandel JL; Boué J; Mattei MG; Mattei JF
    Lancet; 1985 Apr; 1(8433):871. PubMed ID: 2858726
    [No Abstract]   [Full Text] [Related]  

  • 19. Examination of factors that influence the expansion of the fragile X mutation in a sample of conceptuses from known carrier females.
    Sherman SL; Meadows KL; Ashley AE
    Am J Med Genet; 1996 Aug; 64(2):256-60. PubMed ID: 8844059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of fragile X syndrome: management of the male fetus with a premutation.
    Strain L; Porteous ME; Gosden CM; Ellis PM; Neilson JP; Bonthron DT
    Prenat Diagn; 1994 Jun; 14(6):469-74. PubMed ID: 7937584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.